Richard Kevin Masterson is Pres. & COO & Valeant Intl. BB at Valeant Pharmaceuticals International, Inc. (VRX). They have made 1 open-market trade across 1 company since 2012, most recently 2012-05-10.
CIK 0001510875
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRX | 89,524 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2012-05-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRX | SELL | 2012-05-10 | 2012-05-14 | $52.57 | $210 | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.